Scarica l'app Stockscreener
2.07
10.00%
-0.23
Aldeyra Therapeutics Inc Borsa (ALDX) Ultime notizie
ALDX FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 - AOL.com
Aldeyra Therapeutics: What Comes Next After Reproxalap's Third CRL (NASDAQ:ALDX) - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Encourages Aldeyra Therapeutics, Inc. (ALDX) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Aldeyra Therapeutics Inc. (ALDX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
ALDX EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 - AOL.com
ALDX Shareholder Alert: Aldeyra Therapeutics, Inc. Securities Class Action LawsuitInvestors Should Contact The Gross Law Firm - AOL.com
Levicept Ltd (ALDX) Appoints Darlene Deptula-Hicks as CFO Amid P - GuruFocus
Levicept Appoints Darlene Deptula-Hicks as CFO - GlobeNewswire Inc.
Why Did ALDX Stock Tank 70% Today? - Stocktwits
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Shareholders to Reach Out - ACCESS Newswire
ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Aldeyra Therapeutics Inc (ALDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Spotlight On Aldeyra Therapeutics And 2 Other Prominent Penny Stocks - simplywall.st
ALDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Aldeyra Therapeutics, Inc. Actuals & Estimates (TRADEGATE:137) - TradingView
ALDEYRA THERAPEUTICS INC (ALDX) Stock Chart - ChartMill
The Technical Signals Behind (ALDX) That Institutions Follow - Stock Traders Daily
ALDX Stockholders Have Opportunity to Lead Aldeyra Therapeutics - The National Law Review
ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 2000 Value Benchmark - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 2000 Dynamic Index - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 3000E Index - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell Small Cap Completeness Index - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 2500 Index - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 3000 Index - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 2000 Index - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Aldeyra Therapeutics, Inc. (ALDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
137 Forecast — Price Target — Prediction for 2027 - TradingView
Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell 3000E Value Benchmark - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Price to book forward of Aldeyra Therapeutics, Inc. – NASDAQ:ALDX - TradingView
Price to book forward of Aldeyra Therapeutics, Inc. – DUS:137 - TradingView
ALDX Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBITDA forward of Aldeyra Therapeutics, Inc. – NASDAQ:ALDX - TradingView
Enterprise value to EBITDA forward of Aldeyra Therapeutics, Inc. – DUS:137 - TradingView
Enterprise value to revenue forward of Aldeyra Therapeutics, Inc. – NASDAQ:ALDX - TradingView
Enterprise value to revenue forward of Aldeyra Therapeutics, Inc. – DUS:137 - TradingView
Aldeyra Therapeutics, Inc. Actuals & Estimates (NASDAQ:ALDX) - TradingView
Aldeyra appoints Darlene Deptula-Hicks to board of directors By Investing.com - Investing.com Nigeria
Aldeyra Therapeutics, Inc. Actuals & Estimates (DUS:137) - TradingView
Price to earnings forward of Aldeyra Therapeutics, Inc. – NASDAQ:ALDX - TradingView
Price to sales forward of Aldeyra Therapeutics, Inc. – DUS:137 - TradingView
Enterprise value to EBIT forward of Aldeyra Therapeutics, Inc. – NASDAQ:ALDX - TradingView
Price to earnings forward of Aldeyra Therapeutics, Inc. – DUS:137 - TradingView
Bronstein, Gewirtz & Grossman, LLC Is Investigating Aldeyra Therapeutics, Inc. (ALDX) And Encourages Investors to Connect - ACCESS Newswire
Enterprise value to EBIT forward of Aldeyra Therapeutics, Inc. – DUS:137 - TradingView
Aldeyra Therapeutics, Inc. Actuals & Estimates (MUN:137) - TradingView
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc - The National Law Review
Aldeyra Therapeutics Inc (ALDX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bronstein, Gewirtz & Grossman, LLC Encourages Aldeyra Therapeutics, Inc. (ALDX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Precision Trading with Aldeyra Therapeutics Inc. (ALDX) Risk Zones - Stock Traders Daily
2026-06-21 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Investors to Learn More About the Investigation | NDAQ:ALDX | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Investors to Reach Out - ACCESS Newswire
Aldeyra Therapeutics Inc (ALDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aldeyra Therapeutics Inc (ALDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aldeyra Therapeutics Inc (ALDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):